JMVRX | VMVIX | JMVRX / VMVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 18 years | - |
Gain YTD | 10.705 | 11.514 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.4B | 30.5B | 44% |
Annual Yield % from dividends | 1.17 | 2.03 | 58% |
Returns for 1 year | 15.40 | 18.78 | 82% |
Returns for 3 years | -11.65 | 11.54 | -101% |
Returns for 5 years | 7.84 | 46.86 | 17% |
Returns for 10 years | N/A | 89.82 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IFV | 20.58 | 0.23 | +1.13% |
First Trust Dorsey Wright Intl Foc 5 | |||
SPUS | 39.47 | 0.02 | +0.05% |
SP Funds S&P 500 Sharia Industry Ex ETF | |||
CNCR | 14.47 | -0.02 | -0.13% |
Range Cancer Therapeutics ETF | |||
BBCA | 69.73 | -0.20 | -0.29% |
JPMorgan BetaBuilders Canada ETF | |||
PYZ | 86.76 | -0.69 | -0.79% |
Invesco DW Basic Materials Momt ETF |